Self-cross-linked polymer nanogels: a versatile nanoscopic drug delivery platform JH Ryu, RT Chacko, S Jiwpanich, S Bickerton, RP Babu, ... Journal of the American Chemical Society 132 (48), 17227-17235, 2010 | 465 | 2010 |
Longitudinal analyses reveal immunological misfiring in severe COVID-19 C Lucas, P Wong, J Klein, TBR Castro, J Silva, M Sundaram, ... Nature 584 (7821), 463-469, 2020 | 249 | 2020 |
Surface-functionalizable polymer nanogels with facile hydrophobic guest encapsulation capabilities JH Ryu, S Jiwpanich, R Chacko, S Bickerton, S Thayumanavan Journal of the American Chemical Society 132 (24), 8246-8247, 2010 | 178 | 2010 |
Noncovalent encapsulation stabilities in supramolecular nanoassemblies S Jiwpanich, JH Ryu, S Bickerton, S Thayumanavan Journal of the American Chemical Society 132 (31), 10683-10685, 2010 | 151 | 2010 |
Sex differences in immune responses that underlie COVID-19 disease outcomes T Takahashi, MK Ellingson, P Wong, B Israelow, C Lucas, J Klein, J Silva, ... Nature 588 (7837), 315-320, 2020 | 127 | 2020 |
Ligand-decorated nanogels: fast one-pot synthesis and cellular targeting JH Ryu, S Bickerton, J Zhuang, S Thayumanavan Biomacromolecules 13 (5), 1515-1522, 2012 | 67 | 2012 |
Interconnected roles of scaffold hydrophobicity, drug loading, and encapsulation stability in polymeric nanocarriers S Bickerton, S Jiwpanich, S Thayumanavan Molecular pharmaceutics 9 (12), 3569-3578, 2012 | 33 | 2012 |
CaMK4 compromises podocyte function in autoimmune and nonautoimmune kidney disease K Maeda, K Otomo, N Yoshida, MS Abu-Asab, K Ichinose, T Nishino, ... The Journal of clinical investigation 128 (8), 3445-3459, 2018 | 31 | 2018 |
Cutting edge: nanogel-based delivery of an inhibitor of CaMK4 to CD4+ T cells suppresses experimental autoimmune encephalomyelitis and lupus-like disease in mice K Otomo, T Koga, M Mizui, N Yoshida, C Kriegel, S Bickerton, TM Fahmy, ... The Journal of Immunology 195 (12), 5533-5537, 2015 | 28 | 2015 |
Precision DNA demethylation ameliorates disease in lupus-prone mice H Li, MG Tsokos, S Bickerton, A Sharabi, Y Li, VR Moulton, P Kong, ... JCI insight 3 (16), 2018 | 22 | 2018 |
Neurodegenerative disease: a perspective on cell-based therapy in the new era of cell-free nano-therapy S M Metcalfe, S Bickerton, T Fahmy Current pharmaceutical design 23 (5), 776-783, 2017 | 14 | 2017 |
Suppression of Murine Lupus by CD 4+ and CD 8+ Treg Cells Induced by T Cell–Targeted Nanoparticles Loaded With Interleukin‐2 and Transforming Growth Factor ¥â DA Horwitz, S Bickerton, M Koss, TM Fahmy, A La Cava Arthritis & Rheumatology 71 (4), 632-640, 2019 | 12 | 2019 |
Detection of SARS-CoV-2 RNA by multiplex RT-qPCR E Kudo, B Israelow, CBF Vogels, P Lu, AL Wyllie, M Tokuyama, ... PLoS Biology 18 (10), e3000867, 2020 | 7 | 2020 |
Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators B Schwarz, L Sharma, L Roberts, X Peng, S Bermejo, I Leighton, ... The Journal of Immunology 206 (2), 329-334, 2021 | 1 | 2021 |
Anti-CD2 Antibody-Coated Nanoparticles Containing IL-2 Induce NK Cells That Protect Lupus Mice via a TGF-¥â-Dependent Mechanism DA Horwitz, A Liu, S Bickerton, G Castaldo, G Matarese, TM Fahmy, ... Frontiers in Immunology 11, 2020 | | 2020 |
Does Co-Encapsulation Matter?: Probing the Biophysical and Functional Impacts of Nanoparticle Combinatorial Delivery P Han, S Bickerton, S Khan, J Lee, E Song, O Mano, T Fahmy 2018 AIChE Annual Meeting, 2018 | | 2018 |
Tuning the encapsulation stability of nanoparticles for drug delivery containers S Bickerton, S Jiwpanich, JH Ryu, S Thayumanavan American Chemical Society, 2010 | | 2010 |
Tuning the encapsulation stability of nanoparticles for drug delivery containers S Jiwpanich, JH Ryu, S Bickerton, S Thayumanavan ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 240, 2010 | | 2010 |
Direct Comparison of B Cell Surface Receptors as Therapeutic Targets for Nanoparticle Delivery of BTK Inhibitors SN Khan, P Han, R Chaudhury, S Bickerton, JS Lee, B Calderon, ... Molecular Pharmaceutics, 0 | | |